The endoscopic approach and guaiac fecal occult blood test (g-FOBT) are the predominant tools currently used in CRC screening [3–5]. Although the screening strategy has clearly reduced the risk of CRC-associated mortality [6], the limitations in the test performance, access to screening tests and patient compliance compromise the diagnostic validity.